in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (5 days ago)
RT @EU_ToxRisk: Nice paper in "Regulatory Toxicology and Pharmacology" about #PBK models and how they support #regulatory #riskassessment.…
Douglas Connect (2 weeks ago)
RT @barryhardy: Impact of New Methods in #Food and #Drug #Safety #Assessment - Summary from the Global Summit on #Regulatory #Science https…
Douglas Connect (3 weeks ago)
Decision-making about safety assessment is undergoing a major transition. https://t.co/EX5kf9eDZK #OpenTox #safetyassessment
Douglas Connect (4 weeks ago)
OpenTox Euro 2017 is now less than a month away, please reserve your place now! https://t.co/ophtCvO3dX … #OpenTox… https://t.co/lbjpMxV0Vf
Douglas Connect (4 weeks ago)
The October OpenTox Newsletter is now available: https://t.co/fb6MoaKdO3 #OpenTox #safety #science #toxicology

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com